Brief: Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
26/07/2022 22:18
July 26 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS, INC. REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* BLUEJAY DIAGNOSTICS INC - CASH AND CASH EQUIVALENTS ON
JUNE 30,
2022 WERE $15.3 MILLION
* BLUEJAY DIAGNOSTICS INC - QTRLY LOSS PER SHARE $0.10
* BLUEJAY DIAGNOSTICS - EXPECTS CASH SUFFICIENT TO FUND
OPERATIONS
BEYOND DATE OF EXPECTED REGULATORY APPROVAL, COMMERCIALIZATION
OF SYMPHONY IL-6 TEST
Source text for Eikon: ID:nGNX2mMlk2
Further company coverage: BJDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook